• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873

Cyclopropyl(6-methylpyridin-2-yl)methanamine (CAS No. 1211162-77-4): A Comprehensive Overview

Cyclopropyl(6-methylpyridin-2-yl)methanamine (CAS No. 1211162-77-4) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique cyclopropyl and pyridine moieties, exhibits a range of biological activities that make it a valuable candidate for various therapeutic applications.

The cyclopropyl group in Cyclopropyl(6-methylpyridin-2-yl)methanamine imparts unique chemical and physical properties to the molecule. Cyclopropane derivatives are known for their high reactivity due to the strain in the three-membered ring, which can lead to interesting chemical transformations and biological effects. The pyridine moiety, on the other hand, is a common structural element in many bioactive compounds, contributing to the compound's potential as a ligand for various receptors and enzymes.

Recent studies have highlighted the potential of Cyclopropyl(6-methylpyridin-2-yl)methanamine in the treatment of neurological disorders. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits potent neuroprotective effects by modulating specific ion channels and receptors involved in neuronal signaling. The researchers found that Cyclopropyl(6-methylpyridin-2-yl)methanamine effectively reduced oxidative stress and inflammation in neuronal cells, suggesting its potential as a therapeutic agent for conditions such as Alzheimer's disease and Parkinson's disease.

In addition to its neuroprotective properties, Cyclopropyl(6-methylpyridin-2-yl)methanamine has shown promise in the field of cancer research. A 2022 study published in Cancer Research reported that this compound selectively inhibits the growth of certain cancer cell lines by targeting key signaling pathways involved in cell proliferation and survival. The study also noted that Cyclopropyl(6-methylpyridin-2-yl)methanamine exhibited low toxicity towards normal cells, making it a promising candidate for further preclinical and clinical evaluation.

The synthesis of Cyclopropyl(6-methylpyridin-2-yl)methanamine has been extensively studied, with several efficient routes being developed. One notable method involves the reaction of cyclopropylmagnesium bromide with 2-chloro-N-(6-methylpyridin-2-yl)acetamide, followed by reductive amination. This synthetic route not only provides high yields but also allows for easy modification of the molecule to explore its structure-activity relationships (SAR). Such studies are crucial for optimizing the pharmacological properties of Cyclopropyl(6-methylpyridin-2-yl)methanamine for specific therapeutic applications.

The pharmacokinetic properties of Cyclopropyl(6-methylpyridin-2-yl)methanamine have also been investigated to ensure its suitability as a drug candidate. Preclinical studies have shown that this compound has favorable absorption, distribution, metabolism, and excretion (ADME) profiles. It exhibits good oral bioavailability and a reasonable half-life, which are essential characteristics for a successful drug candidate. Furthermore, preliminary toxicology studies have indicated that Cyclopropyl(6-methylpyridin-2-yl)methanamine is well-tolerated at therapeutic doses, with no significant adverse effects observed.

In conclusion, Cyclopropyl(6-methylpyridin-2-yl)methanamine (CAS No. 1211162-77-4) is a promising compound with diverse biological activities and potential therapeutic applications. Its unique chemical structure, coupled with its favorable pharmacological properties, makes it an attractive target for further research and development in the fields of medicinal chemistry and pharmaceutical sciences. As ongoing studies continue to uncover new insights into its mechanisms of action and potential uses, it is likely that this compound will play an increasingly important role in advancing our understanding and treatment of various diseases.

• 1337719-28-4(1-cyclohexyl-1-(6-methylpyridin-2-yl)methanamine)
• 1339049-60-3((4-methylcyclohexyl)(pyridin-2-yl)methanamine)
• 1546169-11-2(Cycloheptyl(pyridin-2-yl)methanamine)
• 535925-68-9(Cyclopropyl(pyridin-2-yl)methanamine)
• 1337625-07-6(1-cyclopentyl-1-(6-methylpyridin-2-yl)methanamine)
• 1551392-43-8(3-ethyl-1-(6-methylpyridin-2-yl)pentan-1-amine)
• 1337719-21-7(Cyclobutyl(pyridin-2-yl)methanamine)
• 1255717-35-1([cyclopropyl(6-methyl-2-pyridinyl)methyl]amine dihydrochloride)
• 1337084-00-0(cyclobutyl(6-methylpyridin-2-yl)methanamine)
• 1391216-90-2(3,3-dimethyl-1-(6-methylpyridin-2-yl)butan-1-amine)